Survival of immunobiological drugs in psoriasis: preliminary data from a Tertiary Hospital experience in Southern Brazil

AUTOR(ES)

Lima, Elis Costa de; Boza, Juliana Catucci; Palominos, Penélope Esther; Xavier, Ricardo Machado; Cestari, Tania Ferreira

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2021-06

RESUMO

Abstract Paracoccidioidomycosis is an endemic systemic mycosis caused by Paracoccidioides brasiliensis complex and P. lutzii. It is a rare disease in non-HIV-induced immunosuppressed individuals. In organ transplant recipients, it is more frequently associated with immunosuppression after kidney transplantation. In a liver transplant patient, only one case has been published in the literature to date. The present report comprises the case of a 47-year-old female patient with disseminated skin lesions associated with signs and symptoms of systemic involvement of paracoccidioidomycosis that manifested one year after liver transplantation and under an immunosuppression regimen with tacrolimus and mycophenolate mofetil.

Documentos Relacionados

• Immunomodulatory drugs for psoriasis: New “biologics” offer much promise
• Anti-TNFα therapy in the management of psoriasis: experience of a state referral center
• Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study
• Viral epidemiology of respiratory infections among children at a tertiary hospital in Southern Brazil
• Oral lesions frequency in HIV-positive patients at a tertiary hospital, Southern Brazil